Oxygen bar

Last updated
Interior of an oxygen bar Oxygen Bar interior, showing flavors.jpg
Interior of an oxygen bar

An oxygen bar is an establishment, or part of one, that sells oxygen for recreational use. Individual scents may be added to enhance the experience. The flavors in an oxygen bar come from bubbling oxygen through bottles containing aromatic solutions before it reaches the nostrils: most bars use food-grade particles to produce the scent, but some bars use aroma oils. [1] [2]

Contents

History

In 1776, Thomas Henry, an apothecary and Fellow of the Royal Society of England speculated tongue in cheek that Joseph Priestley’s newly discovered dephlogisticated air (now called oxygen) might become "as fashionable as French wine at the fashionable taverns". He did not expect, however, that tavern goers would "relish calling for a bottle of Air, instead of Claret." [3]

Another early reference to the recreational use of oxygen is found in Jules Verne's 1870 novel Around the Moon . In this work, Verne states:

Do you know, my friends, that a curious establishment might be founded with rooms of oxygen, where people whose system is weakened could for a few hours live a more active life. Fancy parties where the room was saturated with this heroic fluid, theaters where it should be kept at high pressure; what passion in the souls of the actors and spectators! what fire, what enthusiasm! And if, instead of an assembly only a whole people could be saturated, what activity in its functions, what a supplement to life it would derive. From an exhausted nation they might make a great and strong one, and I know more than one state in old Europe which ought to put itself under the regime of oxygen for the sake of its health!

Modeled after the "air stations" in polluted downtown Tokyo and Beijing, the first oxygen bar (the O2 Spa Bar) opened in Toronto, Canada, in 1996. The trend continued in North America and by the late 1990s, bars were in use in New York, California, Florida, Las Vegas and the Rocky Mountain region. Customers in these bars breathe oxygen through a plastic nasal cannula inserted into their nostrils. [4] Oxygen bars can now be found in many venues such as nightclubs, salons, spas, health clubs, resorts, tanning salons, restaurants, coffee houses, bars, airports, ski chalets, yoga studios, chiropractors, and casinos. They can also be found at trade shows, conventions and corporate meetings, as well as at private parties and promotional events.

Provision of oxygen

Oxygen bar guests pay about one U.S. dollar per minute to inhale a percentage of oxygen greater than the normal atmospheric content of 20.9% oxygen. This oxygen is gathered from the ambient air by an industrial (non-medical) oxygen concentrator and inhaled through a nasal cannula for up to about 20 minutes. [5]

The machines used by oxygen bars or oxygen vendors differ from the typical medical-issue machine, although customers use the cannula, the rubber tube apparatus that fits around the ears and inserts in the nostrils, to breathe in the oxygen. Customers can enhance their experience by using aromatherapy scents to be added to the oxygen, such as lavender or mint. [6]

Health risks and benefit claims

It has been claimed by alternative medicine that the human body is oxygen-deprived, and that oxygen will remove "toxins" and even cure cancer. [7] Proponents claim this practice is not only safe, but enhances health and well-being, including strengthening the immune system, enhancing concentration, reducing stress, increasing energy and alertness, lessening the effects of hangovers, headaches, and sinus problems, and generally relaxing the body. [5] It has also been alleged to help with altitude sickness. However, no long-term, well-controlled scientific studies have confirmed any of the proponents' claims. [5] Furthermore, the human body is adapted to 21 percent oxygen, and the blood exiting the lungs already has about 97 percent of the oxygen that it could carry bound to hemoglobin. Having a higher oxygen fraction in the lungs serves no purpose, and may actually be detrimental. [7]

The medical profession warns that individuals with respiratory diseases such as asthma and emphysema should not inhale too much oxygen. [5] Higher than normal oxygen partial pressure can also indirectly cause carbon dioxide narcosis in patients with chronic obstructive pulmonary disease (COPD). [8] The FDA warns that in some situations, droplets of flavoring oil can be inhaled, which may contribute to an inflammation of the lungs. Some oxygen bar companies offer safe water-based aromas for flavoring in order to maintain compliance and stay within FDA guidelines. [5]

Oxygen may also cause serious side effects at excessive doses. Although the effects of oxygen toxicity at atmospheric pressure can cause lung damage, [9] the low fraction of oxygen (3040%) [10] and relatively brief exposures make pulmonary toxicity unlikely. [11] Nevertheless, due caution should be exercised when consuming oxygen. In the UK, the Health and Safety Executive publishes guidance on equipment (including tubing) and on staff training, as well as warning on potential hazards, and makes several recommendations to ensure safe practice, principally to minimise fire risks. [12]

Another concern is the improper maintenance of oxygen equipment. Some oxygen concentrators use clay filters which cause micro-organisms to grow, creating an additional danger that can cause lung infections. [13]

Safety hazards

Raised concentrations of oxygen increase the risk of ignition, the rate and heat of combustion, and the difficulty of extinguishing a fire. Many materials that will not burn in air will burn in a sufficiently high partial pressure of oxygen.

Regulations

In the United States, the Federal Food, Drug, and Cosmetic Act defines any substance used for breathing and administered by another person as a prescription drug. Melvin Szymanski, a consumer safety officer in the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, has explained that at one end of the hose is a source of oxygen, so the individual providing the hose and turning on the supply is dispensing a prescription drug. [14] He commented that "Although oxygen bars that dispense oxygen without a prescription violate FDA regulations, the agency applies regulatory discretion to permit the individual state boards of licensing to enforce the requirements pertaining to the dispensing of oxygen." [14]

Canadian Society of Respiratory Therapists says that "As health professionals, we cannot ethically or morally support providing oxygen therapy to those who do not require it." [15]

See also

Related Research Articles

<span class="mw-page-title-main">Oxygen toxicity</span> Toxic effects of breathing oxygen at high partial pressures

Oxygen toxicity is a condition resulting from the harmful effects of breathing molecular oxygen at increased partial pressures. Severe cases can result in cell damage and death, with effects most often seen in the central nervous system, lungs, and eyes. Historically, the central nervous system condition was called the Paul Bert effect, and the pulmonary condition the Lorrain Smith effect, after the researchers who pioneered the discoveries and descriptions in the late 19th century. Oxygen toxicity is a concern for underwater divers, those on high concentrations of supplemental oxygen, and those undergoing hyperbaric oxygen therapy.

In physiology, respiration is the movement of oxygen from the outside environment to the cells within tissues, and the removal of carbon dioxide in the opposite direction that's to the environment.

<span class="mw-page-title-main">Oxygen therapy</span> Use of oxygen as a medical treatment

Oxygen therapy, also referred to as supplemental oxygen, is the use of oxygen as medical treatment. Supplemental oxygen can also refer to the use of oxygen enriched air at altitude. Acute indications for therapy include hypoxemia, carbon monoxide toxicity and cluster headache. It may also be prophylactically given to maintain blood oxygen levels during the induction of anesthesia. Oxygen therapy is often useful in chronic hypoxemia caused by conditions such as severe COPD or cystic fibrosis. Oxygen can be delivered via nasal cannula, face mask, or endotracheal intubation at normal atmospheric pressure, or in a hyperbaric chamber. It can also be given through bypassing the airway, such as in ECMO therapy.

<span class="mw-page-title-main">Breathing apparatus</span> Equipment allowing or assisting the user to breath in a hostile environment

A breathing apparatus or breathing set is equipment which allows a person to breathe in a hostile environment where breathing would otherwise be impossible, difficult, harmful, or hazardous, or assists a person to breathe. A respirator, medical ventilator, or resuscitator may also be considered to be breathing apparatus. Equipment that supplies or recycles breathing gas other than ambient air in a space used by several people is usually referred to as being part of a life-support system, and a life-support system for one person may include breathing apparatus, when the breathing gas is specifically supplied to the user rather than to the enclosure in which the user is the occupant.

<span class="mw-page-title-main">Nasal cannula</span> Medical device to deliver supplemental oxygen

The nasal cannula (NC) is a device used to deliver supplemental oxygen or increased airflow to a patient or person in need of respiratory help. This device consists of a lightweight tube which on one end splits into two prongs which are placed in the nostrils curving toward the sinuses behind the nose, and from which a mixture of air and oxygen flows. The other end of the tube is connected to an oxygen supply such as a portable oxygen generator, or a wall connection in a hospital via a flowmeter. The cannula is generally attached to the patient by way of the tube hooking around the patient's ears or by an elastic headband, and the prongs curve toward the paranasal sinuses. The earliest, and most widely used form of adult nasal cannula carries 1–3 litres of oxygen per minute.

Beta<sub>2</sub>-adrenergic agonist Compounds that bind to and activate adrenergic beta-2 receptors

Beta2-adrenergic agonists, also known as adrenergic β2 receptor agonists, are a class of drugs that act on the β2 adrenergic receptor. Like other β adrenergic agonists, they cause smooth muscle relaxation. β2 adrenergic agonists' effects on smooth muscle cause dilation of bronchial passages, vasodilation in muscle and liver, relaxation of uterine muscle, and release of insulin. They are primarily used to treat asthma and other pulmonary disorders, such as Chronic obstructive pulmonary disease (COPD).

Hyperoxia occurs when cells, tissues and organs are exposed to an excess supply of oxygen (O2) or higher than normal partial pressure of oxygen.

<span class="mw-page-title-main">Bronchoconstriction</span> Constriction of the terminal airways in the lungs

Bronchoconstriction is the constriction of the airways in the lungs due to the tightening of surrounding smooth muscle, with consequent coughing, wheezing, and shortness of breath.

<span class="mw-page-title-main">Pneumonitis</span> General inflammation of lung tissue

Pneumonitis describes general inflammation of lung tissue. Possible causative agents include radiation therapy of the chest, exposure to medications used during chemo-therapy, the inhalation of debris, aspiration, herbicides or fluorocarbons and some systemic diseases. If unresolved, continued inflammation can result in irreparable damage such as pulmonary fibrosis.

<span class="mw-page-title-main">Metered-dose inhaler</span> Device that helps deliver a specific amount of medication to the lungs

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

Occupational lung diseases comprise a broad group of diseases, including occupational asthma, industrial bronchitis, chronic obstructive pulmonary disease (COPD), bronchiolitis obliterans, inhalation injury, interstitial lung diseases, infections, lung cancer and mesothelioma. These can be caused directly or due to immunological response to an exposure to a variety of dusts, chemicals, proteins or organisms. Occupational cases of interstitial lung disease may be misdiagnosed as COPD, idiopathic pulmonary fibrosis, or a myriad of other diseases; leading to a delay in identification of the causative agent.

<span class="mw-page-title-main">Respiratory system of the horse</span> Biological system by which a horse circulates air for the purpose of gaseous exchange

The respiratory system of the horse is the biological system by which a horse circulates air for the purpose of gaseous exchange.

<span class="mw-page-title-main">Acute exacerbation of chronic obstructive pulmonary disease</span> Medical condition

An acute exacerbation of chronic obstructive pulmonary disease, or acute exacerbations of chronic bronchitis (AECB), is a sudden worsening of chronic obstructive pulmonary disease (COPD) symptoms including shortness of breath, quantity and color of phlegm that typically lasts for several days.

<span class="mw-page-title-main">Chronic obstructive pulmonary disease</span> Lung disease involving long-term poor airflow

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. The main symptoms of COPD include shortness of breath and a cough, which may or may not produce mucus. COPD progressively worsens, with everyday activities such as walking or dressing becoming difficult. While COPD is incurable, it is preventable and treatable. The two most common types of COPD are emphysema and chronic bronchitis and have been the two classic COPD phenotypes. However, this basic dogma has been challenged as varying degrees of co-existing emphysema, chronic bronchitis, and potentially significant vascular diseases have all been acknowledged in those with COPD, giving rise to the classification of other phenotypes or subtypes. Emphysema is defined as enlarged airspaces (alveoli) whose walls have broken down resulting in permanent damage to the lung tissue. Chronic bronchitis is defined as a productive cough that is present for at least three months each year for two years. Both of these conditions can exist without airflow limitation when they are not classed as COPD. Emphysema is just one of the structural abnormalities that can limit airflow and can exist without airflow limitation in a significant number of people. Chronic bronchitis does not always result in airflow limitation but in young adults who smoke the risk of developing COPD is high. Many definitions of COPD in the past included emphysema and chronic bronchitis, but these have never been included in GOLD report definitions. Emphysema and chronic bronchitis remain the predominant phenotypes of COPD but there is often overlap between them and a number of other phenotypes have also been described. COPD and asthma may coexist and converge in some individuals. COPD is associated with low-grade systemic inflammation.

<span class="mw-page-title-main">Heated humidified high-flow therapy</span> Respiratory support method

Heated humidified high-flow therapy, often simply called high flow therapy, is a type of respiratory support that delivers a flow of medical gas to a patient of up to 60 liters per minute and 100% oxygen through a large bore or high flow nasal cannula. Primarily studied in neonates, it has also been found effective in some adults to treat hypoxemia and work of breathing issues. The key components of it are a gas blender, heated humidifier, heated circuit, and cannula.

Acute inhalation injury may result from frequent and widespread use of household cleaning agents and industrial gases. The airways and lungs receive continuous first-pass exposure to non-toxic and irritant or toxic gases via inhalation. Irritant gases are those that, on inhalation, dissolve in the water of the respiratory tract mucosa and provoke an inflammatory response, usually from the release of acidic or alkaline radicals. Smoke, chlorine, phosgene, sulfur dioxide, hydrogen chloride, hydrogen sulfide, nitrogen dioxide, ozone, and ammonia are common irritants.

<span class="mw-page-title-main">Fluticasone furoate/vilanterol</span> Pharmaceutical drug formulation

Fluticasone furoate/vilanterol (FF/VI), sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β2 agonist (ultra-LABA).

<span class="mw-page-title-main">Umeclidinium bromide</span> Chemical compound

Umeclidinium bromide, sold under the brand name Incruse Ellipta, is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is also approved for this indication in combination with vilanterol and also as a triple-therapy combination as fluticasone furoate/umeclidinium bromide/vilanterol.

Fluticasone furoate/umeclidinium bromide/vilanterol, sold under the brand name Trelegy Ellipta among others, is a fixed-dose combination inhaled medication that is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). The medications work in different ways: fluticasone furoate is an inhaled corticosteroid (ICS), umeclidinium is a long-acting muscarinic antagonist (LAMA), and vilanterol is a long-acting beta-agonist (LABA).

<span class="mw-page-title-main">Glossary of breathing apparatus terminology</span> Definitions of technical terms used in connection with breathing apparatus

A breathing apparatus or breathing set is equipment which allows a person to breathe in a hostile environment where breathing would otherwise be impossible, difficult, harmful, or hazardous, or assists a person to breathe. A respirator, medical ventilator, or resuscitator may also be considered to be breathing apparatus. Equipment that supplies or recycles breathing gas other than ambient air in a space used by several people is usually referred to as being part of a life-support system, and a life-support system for one person may include breathing apparatus, when the breathing gas is specifically supplied to the user rather than to the enclosure in which the user is the occupant.

References

  1. Drahl, Carmen. "The Highs and Lows of Oxygen." Chemical and Engineering News 86.45 (2008):64.
  2. Dispositif de distribution d'oxygène parfumé aux huiles essentielles à usage unique ou multiple pouvant prendre la forme de bars, de fontaines ou de narguilés - Brevet d'invention N° 07 04583 - INPI (France)
  3. Thomas Henry F. R. S. "Essays Physical and Chemical by M. Lavoisier – Translated from the French, with Notes, and an Appendix, by Thomas Henry", note from The London Review of English and Foreign Literature by W. Kenrick, Vol IV, T. Evans, Pater-Noster-Row, 1776, p. 214
  4. Altman, Nathaniel. The Oxygen Prescription: The Miracle of Oxidative Therapies. Rochester: Healing, 2007. 313–14
  5. 1 2 3 4 5 Bren, Linda (November 2002). "Oxygen Bars: Is a Breath of Fresh Air Worth It?". FDA Consumer. U.S. Food and Drug Administration (in FDA Consumer magazine). 36 (6): 9–11. PMID   12523293 . Retrieved 2018-03-14.
  6. Stalling, Ann E., "A breath of fresher air." Ball State Daily News. 27 Feb. 2004:1. Archived June 19, 2009, at the Wayback Machine
  7. 1 2 Wanjek, Christopher. "Suffocating Trends: Oxygen Bars and Drinks." LiveScience (2006): 1. 25 June 2009. http://www.livescience.com/health/060418_bad_oxygen.html
  8. Patel, Dharmeshkumar N; Goel, Ashish; Agarwal, SB; Garg, Praveenkumar; Lakhani, Krishna K (July 2003). "Oxygen toxicity" (PDF). Journal, Indian Academy of Clinical Medicine. 4 (3): 234–37.
  9. Clark, John M; Lambertsen, Christian J (1971). "Pulmonary oxygen toxicity: a review". Pharmacological Reviews. 23 (2): 37–133. PMID   4948324 . Retrieved 2008-10-10.
  10. "Oxygen Delivery Methods." American Thoracic Society. http://www.thoracic.org/clinical/copd-guidelines/for-health-professionals/exacerbation/inpatient-oxygen-therapy/oxygen-delivery-methods.php Archived 2013-07-12 at the Wayback Machine Accessed 9 July 2013.
  11. O'Keefe, Michael F; et al. (1998). "6 Oxygen Therapy". Brady emergency care . Upper Saddle River, NJ: Brady/Prentice Hall. ISBN   0-8359-5073-5.
  12. Gregson, Margaret (May 2008). "Review of developments in the use of oxygen". UK Health and Safety Executive (HSE). Retrieved 2012-09-12.
  13. Chavis, Vicki F., "Oxygen Bars – Health Benefit or Hazard." Natural Medicine 9 Apr. 2009: 2
  14. 1 2 U.S. Food and Drug Administration (28 June 2009). "Oxygen Bars: Healthy or Just Hype". enotalone.com.
  15. Sorgen, Carol. "The Rise of Oxygen Bars." WebMD (2002):1–2. http://www.webmd.com/balance/features/rise-of-oxygen-bars